Expert consensus on the diagnosis and treatment of intrahepatic cholestasis (2021 edition).
10.3760/cma.j.cn501113-20220119-00033
- Collective Name:National Center for Clinical Research of Infectious Diseases
- Publication Type:Journal Article
- Keywords:
Diagnosis;
Intrahepatic cholestasis;
Liver diseases;
Treatment
- MeSH:
Bile;
Bile Acids and Salts;
Cholestasis/complications*;
Cholestasis, Intrahepatic/therapy*;
Consensus;
Female;
Humans;
Pregnancy
- From:
Chinese Journal of Hepatology
2022;30(2):137-146
- CountryChina
- Language:Chinese
-
Abstract:
Intrahepatic cholestasis is a clinical syndrome due to the defect of bile acid synthesis, abnormal bile excretion, and mechanical or functional disturbance of intrahepatic bile flows caused by hepatic parenchymal cell and/or intrahepatic bile duct diseases. It commonly occurs as cholestatic liver diseases, intrahepatic cholestasis of pregnancy, and genetic/metabolic-related cholestatic diseases. In recent years, new information and progress in diagnosis and treatment of intrahepatic cholestatic diseases have been achieved. In order to provide updated clinical reference and guidance for clinicians, we organized experts to compile the Expert Consensus on the Diagnosis and Treatment of Intrahepatic Cholestasis (2021), on the basis of the 2015 edition.
